How can pharma and biotech companies improve their supply planning and distribution? Which system requirements should be considered?
Clinical Trials has always been a complex ecosystem to operate in, even more so with disruption and challenges faced due to the pandemic and issues such as the supply chain, the shift to Decentralised Trials, patient recruitment, negative impacts on sites and skills shortages, to name but a few. Whilst the industry has transformed in many ways to adapt to the challenges, on the whole, the tools used for IRT/RTSM and clinical drug supply forecasting, planning and management have not changed much and many are not designed to handle the complexities of the world we live in now.
Selecting an appropriate solution can seem like a real challenge, but it needn’t be.
Watch this webinar to learn more about the questions you should ask and the impact that a good or bad selection can make on your business.
- Which features in a Supply Forecasting and RTSM system are required to reliably reduce costs and anticipate risks?
- How can forecasting models can be leveraged to optimise clinical supply management?
- Why a Supply Forecasting Tool must speak the same language as the RTSM?
- When should you begin looking for a solution?
- How can you proceed?
- How can you investigate potential scenarios?
- How can mitigate the impact from potential recruitment delays?
- How can you analyse the impact from study changes on supply management?
- How can a harmonized Supply forecasting and IRT solution reduce costs and risks?
